These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
501 related articles for article (PubMed ID: 22047130)
1. Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis. Virgili N; Espinosa-Parrilla JF; Mancera P; Pastén-Zamorano A; Gimeno-Bayon J; Rodríguez MJ; Mahy N; Pugliese M J Neuroinflammation; 2011 Nov; 8():149. PubMed ID: 22047130 [TBL] [Abstract][Full Text] [Related]
2. Effects of the PPAR-beta agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination. Defaux A; Zurich MG; Braissant O; Honegger P; Monnet-Tschudi F J Neuroinflammation; 2009 May; 6():15. PubMed ID: 19422681 [TBL] [Abstract][Full Text] [Related]
3. K(ATP) channel opener diazoxide prevents neurodegeneration: a new mechanism of action via antioxidative pathway activation. Virgili N; Mancera P; Wappenhans B; Sorrosal G; Biber K; Pugliese M; Espinosa-Parrilla JF PLoS One; 2013; 8(9):e75189. PubMed ID: 24040400 [TBL] [Abstract][Full Text] [Related]
4. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation. Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550 [TBL] [Abstract][Full Text] [Related]
5. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses. Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996 [TBL] [Abstract][Full Text] [Related]
6. Diosgenin ameliorates cellular and molecular changes in multiple sclerosis in C57BL/6 mice. Zeinali H; Baluchnejadmojarad T; Roghani M Mult Scler Relat Disord; 2021 Oct; 55():103211. PubMed ID: 34425463 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis. Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622 [TBL] [Abstract][Full Text] [Related]
8. Alendronate alleviates the symptoms of experimental autoimmune encephalomyelitis. Jung K; Kim J; Ahn G; Matsuda H; Akane T; Ahn M; Shin T Int Immunopharmacol; 2020 Jul; 84():106534. PubMed ID: 32361191 [TBL] [Abstract][Full Text] [Related]
9. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling. Zhang D; Qiao L; Fu T Biomed Pharmacother; 2020 May; 125():109528. PubMed ID: 32106388 [TBL] [Abstract][Full Text] [Related]
10. RAM-589.555 favors neuroprotective and anti-inflammatory profile of CNS-resident glial cells in acute relapse EAE affected mice. Zilkha-Falb R; Rachutin-Zalogin T; Cleaver L; Gurevich M; Achiron A J Neuroinflammation; 2020 Oct; 17(1):313. PubMed ID: 33081798 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of bornyl acetate on experimental autoimmune encephalomyelitis via anti-inflammatory effects and maintaining blood-brain-barrier integrity. Lee JI; Choi JH; Kwon TW; Jo HS; Kim DG; Ko SG; Song GJ; Cho IH Phytomedicine; 2023 Apr; 112():154569. PubMed ID: 36842217 [TBL] [Abstract][Full Text] [Related]
12. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation. Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198 [TBL] [Abstract][Full Text] [Related]
13. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. Kozela E; Lev N; Kaushansky N; Eilam R; Rimmerman N; Levy R; Ben-Nun A; Juknat A; Vogel Z Br J Pharmacol; 2011 Aug; 163(7):1507-19. PubMed ID: 21449980 [TBL] [Abstract][Full Text] [Related]
14. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Craner MJ; Damarjian TG; Liu S; Hains BC; Lo AC; Black JA; Newcombe J; Cuzner ML; Waxman SG Glia; 2005 Jan; 49(2):220-9. PubMed ID: 15390090 [TBL] [Abstract][Full Text] [Related]
15. Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice. Valero-Esquitino V; Lucht K; Namsolleck P; Monnet-Tschudi F; Stubbe T; Lucht F; Liu M; Ebner F; Brandt C; Danyel LA; Villela DC; Paulis L; Thoene-Reineke C; Dahlöf B; Hallberg A; Unger T; Sumners C; Steckelings UM Clin Sci (Lond); 2015 Jan; 128(2):95-109. PubMed ID: 25052203 [TBL] [Abstract][Full Text] [Related]
16. Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice. Rahimi A; Faizi M; Talebi F; Noorbakhsh F; Kahrizi F; Naderi N Neuroscience; 2015 Apr; 290():279-87. PubMed ID: 25637488 [TBL] [Abstract][Full Text] [Related]
17. The Anti-Inflammatory Effect of Sulforaphane in Mice with Experimental Autoimmune Encephalomyelitis. Yoo IH; Kim MJ; Kim J; Sung JJ; Park ST; Ahn SW J Korean Med Sci; 2019 Jul; 34(28):e197. PubMed ID: 31327180 [TBL] [Abstract][Full Text] [Related]
19. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia. Fang M; Yamasaki R; Li G; Masaki K; Yamaguchi H; Fujita A; Isobe N; Kira JI Front Immunol; 2018; 9():2588. PubMed ID: 30464764 [TBL] [Abstract][Full Text] [Related]